raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:853

Fetal and neonatal alloimmune thrombocytopenia

Synonyms: FNAIT · NAIT

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
Antenatal, Neonatal
Status
active

A rare hematological disease characterized by maternal alloimmunisation against fetal platelet antigens that are inherited from the father and different from those present in the mother, and usually presents as a severe isolated thrombocytopenia in otherwise healthy newborns.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enFetal and neonatal alloimmune thrombocytopeniaFNAIT · NAIT
frThrombopénie materno-foetale et néonatale allo-immuneNAIT · TNAI
deAlloimmunthrombozytopenie, fetale und neonataleFNAIT
esTrombocitopenia aloinmune fetal y neonatalNAIT
itTrombocitopenia alloimmune fetale e neonataleNAIT
nlFoetale en neonatale allo-immune trombocytopenie= en
ptTrombocitopenia aloimune fetal e neo-natal
plAlloimmunologiczna małopłytkowość płodowo/noworodkowaNAIT
csFetální a novorozenecká aloimunitní trombocytopénieNAIT
ukАлоімунна тромбоцитопенія плода та новонароджених= en
zh胎儿和新生儿同种免疫性血小板减少症FNAIT
trFetal ve Yenidoğan alloimmün trombositopeniNAIT · FNAIT

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10P61.0NTBTattributedvalidated
ICD-113B64.00NTBTindexvalidated
MONDO0019415Evalidated
UMLSC3854603Evalidated
GARD2295Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

6 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
CD109Candidate gene tested inNot yet assessedHGNC:21685ENSG000001565356088596q13CD109 molecule
GP1BACandidate gene tested inNot yet assessedHGNC:4439ENSG0000018524560667217p13.2glycoprotein Ib platelet subunit alpha
GP1BBCandidate gene tested inNot yet assessedHGNC:4440ENSG0000020361813872022q11.21glycoprotein Ib platelet subunit beta
ITGA2Candidate gene tested inNot yet assessedHGNC:6137ENSG000001641711929745q11.2integrin subunit alpha 2
ITGA2BCandidate gene tested inNot yet assessedHGNC:6138ENSG0000000596160775917q21.31integrin subunit alpha 2b
ITGB3Major susceptibility factor inAssessedHGNC:6156ENSG0000025920717347017q21.32integrin subunit beta 319821948[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Point prevalence1-5 / 10 00039.6307 / 100 000WorldwideValue and classValidated23384054[PMID]_ORPHANET
Prevalence at birth6-9 / 10 00066.6667 / 100 000WorldwideValue and classValidated23384054[PMID]_ORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

17 annotations · validated 2019-05-17
HPOTerm (as annotated by Orphanet)Diagnostic
Obligate (100%)
HP:0004809Neonatal alloimmune thrombocytopenia
Frequent (79-30%)
HP:0001892Abnormal bleeding
HP:0012541Cephalohematoma
HP:0000967Petechiae
HP:0000979Purpura
HP:0007420Spontaneous hematomas
Occasional (29-5%)
HP:0031364Ecchymosis
HP:0002239Gastrointestinal hemorrhage
HP:0000790Hematuria
HP:0002170Intracranial hemorrhage
HP:0002249Melena
Very rare (<4-1%)
HP:0000707Abnormality of the nervous system
HP:0008619Bilateral sensorineural hearing impairment
HP:0000618Blindness
HP:0100021Cerebral palsy
HP:0001263Global developmental delay
HP:0002138Subarachnoid hemorrhage

Run the differential on the 1 obligate / very frequent terms

Annotation source: 30827816[PMID]_17032445[PMID]_30971767[PMID]_30828796[PMID]

7

Sources for this card